a new drug for hypertension, Micardis (telmisartan)

October 1999

Boehringer Ingelheim and Glaxo are co-marketing a new drug for hypertension, Micardis (telmisartan).

It's the 5th angiotensin II receptor blocker...joining Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), and Atacand (candesartan).

A 6th one, Teveten (eprosartan, Solvay), will be out soon.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Internet pharmacy is exploding
Asthma Advair, the first inhaler that combines BOTH a long-acting bronchodilator (salmeterol) and corticosteroid (fluticasone)
Diabetes monitor their average WEEKLY blood sugar at home
cautioning that glucosamine might increase blood sugar in patients with diabetes
minocycline or doxycycline for rheumatoid arthritis
Hypertension a new drug for hypertension, Micardis (telmisartan)
treat EARLY stages of Parkinson's with a dopamine agonist
new warnings about sudden sleep attacks in patients taking Mirapex (pramipexole)
HPB is taking Cylert (pemoline) off the market in Canada
Gastroenterology advise patients taking opioid analgesics how to prevent and treat constipation
Infectious Diseases Monurol (fosfomycin), the first SINGLE-dose antibiotic for bladder infections
Infectious Diseases a new topical cream for external genital and perianal warts called Aldara (imiquimod)
Women's Health topical progesterone creams
Women's Health routine screening of pregnant women for hypothyroidism
Hematology & Oncology using Celebrex (celecoxib) and similar drugs to prevent and treat colon cancer
Antithrombotics long-term warfarin might increase the risk of bone fractures